These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11878879)

  • 1. Amphotropic murine leukemia virus replication in human mammary epithelial cells and the formation of cytomegalovirus-promoter recombinants.
    Reuss FU; Heber R; Ploss A; Berdel B
    Virology; 2001 Dec; 291(1):91-100. PubMed ID: 11878879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancer-deficient amphotropic murine leukemia virus and recombinants with heterologous transcription elements can be efficiently amplified and detected in Mus dunni fibroblasts.
    Reuss FU; Berdel B; Heber R; Ploss M
    Gene Ther; 2002 Sep; 9(17):1183-8. PubMed ID: 12170382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication of enhancer-deficient amphotropic murine leukemia virus in human cells.
    Reuss FU; Berdel B; Ploss M; Heber R
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10898-903. PubMed ID: 11535815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional inactivation of amphotropic murine leukemia virus replication in human cells.
    Ploss M; Berdel B; Heber R; Reuss FU
    J Med Virol; 2003 Feb; 69(2):267-72. PubMed ID: 12683417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication of enhancer-deficient amphotropic murine leukemia virus in human fibrosarcoma but not in primary human fibroblasts.
    Reuss FU; Berdel B; Heber R; Bantel-Schaal U
    J Med Virol; 2002 Oct; 68(2):278-84. PubMed ID: 12210420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alleviation of murine leukemia virus repression in embryonic carcinoma cells by genetically engineered primer binding sites and artificial tRNA primers.
    Modin C; Lund AH; Schmitz A; Duch M; Pedersen FS
    Virology; 2000 Dec; 278(2):368-79. PubMed ID: 11118360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors.
    Hlavaty J; Schittmayer M; Stracke A; Jandl G; Knapp E; Felber BK; Salmons B; Günzburg WH; Renner M
    Virology; 2005 Oct; 341(1):1-11. PubMed ID: 16054668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable integration of a functional shRNA expression cassette into the murine leukemia virus genome.
    Sliva K; Schnierle BS
    Virology; 2006 Jul; 351(1):218-25. PubMed ID: 16631223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus.
    Rasmussen MH; Sørensen AB; Morris DW; Dutra JC; Engelhard EK; Wang CL; Schmidt J; Pedersen FS
    Virology; 2005 Jul; 337(2):353-64. PubMed ID: 15913695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine leukemia virus (MLV) replication monitored with fluorescent proteins.
    Sliva K; Erlwein O; Bittner A; Schnierle BS
    Virol J; 2004 Dec; 1():14. PubMed ID: 15610559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient replication of full-length murine leukemia viruses modified at the dimer initiation site regions.
    Aagaard L; Rasmussen SV; Mikkelsen JG; Pedersen FS
    Virology; 2004 Jan; 318(1):360-70. PubMed ID: 14972561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatively initiated gene 50/RTA transcripts expressed during murine and human gammaherpesvirus reactivation from latency.
    Gray KS; Allen RD; Farrell ML; Forrest JC; Speck SH
    J Virol; 2009 Jan; 83(1):314-28. PubMed ID: 18971285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine leukemia virus vector integration favors promoter regions and regional hot spots in a human T-cell line.
    Tsukahara T; Agawa H; Matsumoto S; Matsuda M; Ueno S; Yamashita Y; Yamada K; Tanaka N; Kojima K; Takeshita T
    Biochem Biophys Res Commun; 2006 Jul; 345(3):1099-107. PubMed ID: 16713998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A murine leukemia virus derived retroviral vector with a rat VL30 packaging psi sequence.
    Torrent C; Wang P; Darlix JL
    Bone Marrow Transplant; 1992; 9 Suppl 1():143-7. PubMed ID: 1324044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphate depletion enhances the stability of the amphotropic murine leukemia virus receptor mRNA.
    Chien ML; O'Neill E; Garcia JV
    Virology; 1998 Jan; 240(1):109-17. PubMed ID: 9448695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis of murine cytomegalovirus using a Tn3-based transposon.
    Zhan X; Lee M; Abenes G; Von Reis I; Kittinunvorakoon C; Ross-Macdonald P; Snyder M; Liu F
    Virology; 2000 Jan; 266(2):264-74. PubMed ID: 10639313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WPRE-mediated enhancement of gene expression is promoter and cell line specific.
    Klein R; Ruttkowski B; Knapp E; Salmons B; Günzburg WH; Hohenadl C
    Gene; 2006 May; 372():153-61. PubMed ID: 16488559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
    Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
    Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of retroviral vectors with enhanced efficiency of transgene expression.
    Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
    J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of reverse transcriptase activity in human melanoma cell lines and identification of a murine leukemia virus contaminant.
    Deichmann M; Huder JB; Kleist C; Näher H; Schüpbach J; Böni J
    Arch Dermatol Res; 2005 Feb; 296(8):345-52. PubMed ID: 15630577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.